ALDX

ALDEYRA THERAPEUTICS INC

ALDX·01438T106·US·Common Stock·Healthcare - Biotechnology-13D/G

ALDX (ALDEYRA THERAPEUTICS INC) is held by 71 institutional investors as of Q2 2026. Largest holders: AQR CAPITAL MANAGEMENT LLC ($8M), VANGUARD CAPITAL MANAGEMENT LLC ($5M), D. E. Shaw & Co., Inc. ($4.1M). Net institutional sentiment: Mixed.

71
Holders
(7 Elite)
$49.9M
Total Value
39% (85)
Consensus
33 buying - 52 selling
13F: Insider & Congress: Updated regularly
ALDX

Smart Money Verdict

View all
Loading verdict
Held by 71 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Mar 20, 2026 · Activists Aug 12, 2026 · Congress none

ActivistAQR Capital Management, LLCAQR Capital Management, LLC6.2%Aug 12, 2026
ActivistBlackRock, Inc.BlackRock, Inc.1.7%Jul 27, 2026
ActivistPAPerceptive Advisors LLC0.0%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.8M(+32.6%)$8M0.0%-64.44%
35
Decreased
2.4M(-0.1%)$5M0.0%-70.94%
0
Increased
1.9M(+38.2%)$4.1M0.0%-63.11%
35
Increased
1.5M(+1062.0%)$3.2M0.0%-37.77%
43
Increased
1.4M(+41.9%)$2.9M0.0%-65.88%
35
Decreased
1.3M(-66.6%)$2.7M0.0%-70.21%
0
Increased
1.1M(+1196.3%)$2.4M0.0%-37.15%
42
Increased
882,000(+2.2%)$1.9M0.0%-70.06%
26
Decreased
794,863(-1.6%)$1.7M0.0%-70.94%
0
Increased
725,444(+33.6%)$1.5M0.0%-65.71%
33
Decreased
646,840(-18.8%)$1.4M0.0%-66.19%
0
Increased
608,321(+17.3%)$1.3M0.0%-63.79%
30
Decreased
596,029(-52.4%)$1.3M0.0%-80.51%
0
Decreased
529,083(-15.2%)$1.1M0.0%-81.80%
0
New
421,178$897,1090.0%-30.28%
34
Increased
379,144(+42.4%)$807,5760.0%-64.84%
33
Decreased
360,350(-63.8%)$767,5460.0%-70.96%
0
Decreased
301,940(-43.8%)$643,1320.0%-71.25%
0
Decreased
298,242(-11.9%)$635,2550.0%-70.94%
0
Increased
254,777(+238.9%)$542,6750.0%-50.89%
39

Showing 1-20 of 90

1 / 5
ALDXALDXALDEYRA THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used